Search results
Results From The WOW.Com Content Network
The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation” provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation. METHODS
For atrial fibrillation, also called AFib or AF, the guidelines include some basic decisions that every AFib patient should understand. Treatments will vary depending on your diagnosis. Treatment options may include: Medications. Nonsurgical procedures.
Test your in-depth knowledge of this guideline with CME, CE and MOC educational activities. Clinical Case Series on Atrial Fibrillation: One Size Fits All? Apps and Tools. Use these for critical decision making at the point-of-care. JACC Atrial Fibrillation Guideline Interactive Tool
The following are key perspectives from the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation (AF): The current guideline's classification of AF focuses on the stages of AF including the pre-detection period.
The JACC Interactive Illustration for the AHA/ACC/ACCP/HRS Atrial Fibrillation Guideline focuses on understanding which patients are more likely to benefit from catheter ablation as first-line therapy for rhythm control. The tool is accessible at https://www.jacc.org/guidelines/AtrialFibrillation/interactive.
Aim: The "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation" provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation.
New recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.
The aim of the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation is to provide recommendations that guide clinicians in the treatment of patients with atrial fibrillation.
The newest clinical guideline released by the ACC and the American Heart Association (AHA) provides new and updated recommendations for preventing and optimally managing atrial fibrillation (AFib).
This guideline issues new recommendations for atrial fibrillation and thromboembolic risk assessment, anticoagulation, occlusion of the left atrial appendage, AFib catheter ablation, prevention of and risk modification for this patient population.